BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8755323)

  • 1. [Infectious gastroenteritis in relapses of inflammatory bowel disease. Therapeutic implications].
    Baliellas C; Xiol X; Barenys M; Saavedra J; Casanovas T; Iborra M; Sesé E
    Rev Esp Enferm Dig; 1996 Jun; 88(6):419-22. PubMed ID: 8755323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.
    Jess T; Simonsen J; Nielsen NM; Jørgensen KT; Bager P; Ethelberg S; Frisch M
    Gut; 2011 Mar; 60(3):318-24. PubMed ID: 21193449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of infective intestinal complications on the course of Crohn's disease and ulcerative rectocolitis].
    Romagnoli AM; Corradini P; Matergi M; Schiaroli G; Moschini G; Incandela L; Galassi L
    Clin Ter; 1993 Jan; 142(1):53-9. PubMed ID: 8472512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease.
    Castiglione F; Pignata S; Morace F; Sarubbi A; Baratta MA; D'Agostino L; D'Arienzo A; Mazzacca G
    Ital J Gastroenterol; 1996 May; 28(4):199-204. PubMed ID: 8842834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter jejuni enterocolitis presenting as inflammatory bowel disease.
    Quondamcarlo C; Valentini G; Ruggeri M; Forlini G; Fenderico P; Rossi Z
    Tech Coloproctol; 2003 Oct; 7(3):173-7. PubMed ID: 14628162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
    Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
    Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease.
    Kallinowski F; Wassmer A; Hofmann MA; Harmsen D; Heesemann J; Karch H; Herfarth C; Buhr HJ
    Hepatogastroenterology; 1998; 45(23):1552-8. PubMed ID: 9840104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of inflammatory bowel disease in adults.
    Katz JA
    J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Salmonellosis and ulcerative colitis. A case report and review of the literature].
    Martínez Avilés P; Moreno Carazo A; Bellkessam N; Arnal Arambillet P
    Rev Clin Esp; 1993 Feb; 192(3):116-9. PubMed ID: 8465046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of inflammatory bowel disease in patients with airways disease.
    Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
    Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.
    Pozler O; Maly J; Bonova O; Dedek P; Frühauf P; Havlickova A; Janatova T; Jimramovsky F; Klimova L; Klusacek D; Kocourkova D; Kolek A; Kotalova R; Marx D; Nevoral J; Petro R; Petru O; Plasilova I; Seidl Z; Sekyrova I; Semendak N; Schreierova I; Stanek J; Sykora J; Sulakova A; Toukalkova L; Travnickova R; Volf V; Zahradnicek L; Zenisková I
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):186-9. PubMed ID: 16456413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients.
    Navarro-Llavat M; Domènech E; Bernal I; Sánchez-Delgado J; Manterola JM; Garcia-Planella E; Mañosa M; Cabré E; Gassull MA
    Digestion; 2009; 80(1):25-9. PubMed ID: 19439968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric antimicrobial therapy and infectious diarrhea. Do we need local guidelines?
    Maragkoudakis S; Poulidaki SR; Papadomanolaki E; Alevraki G; Papadogianni M; Oikonomou N; Fanourgiakis P
    Eur J Intern Med; 2011 Oct; 22(5):e60-2. PubMed ID: 21925045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
    Casellas F; López Vivancos J; Malagela JR
    Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.